Opzelura is under clinical development by Incyte and currently in Phase II for Unspecified Dermatological Disorders.

seborrhea. It was under development for the treatment of alopecia areata and plaque psoriasis. GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and ...